$EXE
EXPAND ENERGY Corp Stock $exe

$exe Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000089512624000055 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$505.0M	$1.081B
YoY Change	-64.41%	-67.92%
Cost Of Revenue	$221.0M	$261.0M
YoY Change	-34.23%	-43.75%
Gross Profit	$282.0M	$812.0M
YoY Change	-73.96%	-68.42%
Gross Profit Margin	55.84%	75.12%
Selling, General & Admin	$188.0M	$370.0M
YoY Change	-70.72%	-46.06%
% of Gross Profit	66.67%	45.57%
Research & Development	$3.000M	$2.000M
YoY Change	-62.5%	-71.43%
% of Gross Profit	1.06%	0.25%
Depreciation & Amortization	$348.0M	$399.0M
YoY Change	-7.45%	2.31%
% of Gross Profit	123.4%	49.14%
Operating Expenses	$555.0M	$788.0M
YoY Change	-46.38%	-27.44%
Operating Profit	-$294.0M	$32.00M
YoY Change	-712.5%	-98.24%
Interest Expense	-$20.00M	$19.00M
YoY Change	-9.09%	-48.65%
% of Operating Profit		59.38%
Other Income/Expense, Net	-$1.000M	$1.000M
YoY Change	-104.35%	-103.7%
Pretax Income	-$295.0M	$33.00M
YoY Change	-156.95%	-98.16%
Income Tax	-$68.00M	$7.000M
% Of Pretax Income		21.21%
Net Earnings	-$227.0M	$26.00M
YoY Change	-158.06%	-98.13%
Net Earnings / Revenue	-44.95%	2.41%
Basic Earnings Per Share	-$1.73	$0.20
Diluted Earnings Per Share	-$1.73	$0.18
COMMON SHARES
Basic Shares Outstanding	131.0M shares	130.8M shares
Diluted Shares Outstanding	131.2M shares	141.8M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.019B	$1.179B
YoY Change	12.85%	806.92%
Cash & Equivalents	$1.019B	$1.179B
Short-Term Investments
Other Short-Term Assets	$207.0M	$218.0M
YoY Change	-67.96%	-9.92%
Inventory
Prepaid Expenses
Receivables	$350.0M	$314.0M
Other Receivables	$128.0M	$150.0M
Total Short-Term Assets	$2.013B	$2.378B
YoY Change	-9.32%	-9.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.00B	$10.06B
YoY Change	-6.09%	-4.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$577.0M	$611.0M
YoY Change	-62.92%	77.62%
Total Long-Term Assets	$11.60B	$11.64B
YoY Change	-5.03%	-2.69%
TOTAL ASSETS
Total Short-Term Assets	$2.013B	$2.378B
Total Long-Term Assets	$11.60B	$11.64B
Total Assets	$13.61B	$14.02B
YoY Change	-5.69%	-3.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$274.0M	$317.0M
YoY Change	-57.32%	-49.76%
Accrued Expenses	$140.0M	$153.0M
YoY Change	-74.77%	-38.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$931.0M	$1.020B
YoY Change	-43.61%	-46.26%
LONG-TERM LIABILITIES
Long-Term Debt	$2.021B	$2.025B
YoY Change	-0.74%	-0.74%
Other Long-Term Liabilities	$19.00M	$21.00M
YoY Change	-94.51%	-57.14%
Total Long-Term Liabilities	$2.040B	$2.046B
YoY Change	-14.36%	-2.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$931.0M	$1.020B
Total Long-Term Liabilities	$2.040B	$2.046B
Total Liabilities	$3.238B	$3.336B
YoY Change	-19.71%	-22.56%
SHAREHOLDERS EQUITY
Retained Earnings	$4.601B	$4.923B
YoY Change	-1.46%	8.13%
Common Stock	$1.000M	$1.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.37B	$10.68B
YoY Change
Total Liabilities & Shareholders Equity	$13.61B	$14.02B
YoY Change	-5.69%	-3.93%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$227.0M	$26.00M
YoY Change	-158.06%	-98.13%
Depreciation, Depletion And Amortization	$348.0M	$399.0M
YoY Change	-7.45%	2.31%
Cash From Operating Activities	$209.0M	$552.0M
YoY Change	-59.42%	-37.91%
INVESTING ACTIVITIES
Capital Expenditures	$302.0M	$421.0M
YoY Change	-43.02%	-15.29%
Acquisitions
YoY Change
Other Investing Activities	$36.00M	$47.00M
YoY Change	-96.34%	-94.73%
Cash From Investing Activities	-$266.0M	-$374.0M
YoY Change	-158.72%	-194.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-102.0M	-$77.00M
YoY Change	-46.32%	-93.98%
NET CHANGE
Cash From Operating Activities	209.0M	$552.0M
Cash From Investing Activities	-266.0M	-$374.0M
Cash From Financing Activities	-102.0M	-$77.00M
Net Change In Cash	-159.0M	$101.0M
YoY Change	-120.44%	1920.0%
FREE CASH FLOW
Cash From Operating Activities	$209.0M	$552.0M
Capital Expenditures	$302.0M	$421.0M
Free Cash Flow	-$93.00M	$131.0M
YoY Change	520.0%	-66.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	172000000	usd
CY2023Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	930000000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8000000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	335000000	usd
CY2024Q1	us-gaap	Revenues Revenues	1081000000	usd
CY2023Q1	us-gaap	Revenues Revenues	3370000000	usd
CY2024Q1	us-gaap	Results Of Operations Production Or Lifting Costs ResultsOfOperationsProductionOrLiftingCosts	59000000	usd
CY2023Q1	us-gaap	Results Of Operations Production Or Lifting Costs ResultsOfOperationsProductionOrLiftingCosts	131000000	usd
CY2024Q1	us-gaap	Results Of Operations Transportation Costs ResultsOfOperationsTransportationCosts	173000000	usd
CY2023Q1	us-gaap	Results Of Operations Transportation Costs ResultsOfOperationsTransportationCosts	264000000	usd
CY2024Q1	us-gaap	Production Tax Expense ProductionTaxExpense	29000000	usd
CY2023Q1	us-gaap	Production Tax Expense ProductionTaxExpense	69000000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	2000000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	7000000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	390000000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-17000000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3000000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	1049000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	1550000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	32000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1820000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	19000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	37000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1389000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	390000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	378000000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1793000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	404000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	26000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1389000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1389000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.31
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.60
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130893000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134742000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141752000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144731000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	26000000	usd
CY2024Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	172000000	usd
CY2023Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	930000000	usd
CY2024Q1	chk	Cash Received Paid On Derivative Settlements CashReceivedPaidOnDerivativeSettlements	228000000	usd
CY2023Q1	chk	Cash Received Paid On Derivative Settlements CashReceivedPaidOnDerivativeSettlements	-285000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7000000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8000000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	335000000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	13000000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-12000000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-76000000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-263000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	552000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	889000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	421000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	497000000	usd
CY2024Q1	chk	Receipts Of Deferred Consideration ReceiptsOfDeferredConsideration	60000000	usd
CY2023Q1	chk	Receipts Of Deferred Consideration ReceiptsOfDeferredConsideration	0	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19000000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	39000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	931000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-374000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	395000000	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1000000000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2050000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	54000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	77000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	175000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-77000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1279000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	101000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1153000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	192000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1254000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1179000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	130000000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	75000000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	67000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1254000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	20000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	41000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	chk	Operating Lease Liability Recognized OperatingLeaseLiabilityRecognized	0	usd
CY2023Q1	chk	Operating Lease Liability Recognized OperatingLeaseLiabilityRecognized	48000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9124000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5000000	usd
CY2023Q1	chk	Adjustments To Additional Paid In Capital Warrant Exercise AdjustmentsToAdditionalPaidInCapitalWarrantExercise	0	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1389000000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	175000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10283000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10729000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4000000	usd
CY2024Q1	chk	Adjustments To Additional Paid In Capital Warrant Exercise AdjustmentsToAdditionalPaidInCapitalWarrantExercise	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	26000000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	77000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	10682000000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	75000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	314000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	593000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	26000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1389000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1389000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130893000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134742000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	10302000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	9560000	shares
CY2024Q1	chk	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits	379000	shares
CY2023Q1	chk	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits	380000	shares
CY2024Q1	chk	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits	178000	shares
CY2023Q1	chk	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits	49000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141752000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144731000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.31
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.60
CY2024Q1	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	80000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	83000000	usd
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5000000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2025000000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1950000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2028000000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1943000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	287000000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	360000000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	153000000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	211000000	usd
CY2024Q1	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	2000000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28000000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	64000000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	90000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	84000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	61000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	84000000	usd
CY2024Q1	chk	Joint Interest Advances Current JointInterestAdvancesCurrent	5000000	usd
CY2023Q4	chk	Joint Interest Advances Current JointInterestAdvancesCurrent	8000000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	33000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	34000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	657000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	847000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1793000000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024Q1	chk	Effective Income Tax Rate Current Tax Expense EffectiveIncomeTaxRateCurrentTaxExpense	0
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26000000	usd
CY2023Q1	chk	Effective Income Tax Rate Current Tax Expense EffectiveIncomeTaxRateCurrentTaxExpense	0.015
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000000	usd
CY2024Q1	chk	Effective Income Tax Rate Deferred Tax Expense EffectiveIncomeTaxRateDeferredTaxExpense	0.212
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	378000000	usd
CY2023Q1	chk	Effective Income Tax Rate Deferred Tax Expense EffectiveIncomeTaxRateDeferredTaxExpense	0.210
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.212
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	404000000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.225
CY2024Q1	chk	Estimated Effective Income Tax Rate Percent EstimatedEffectiveIncomeTaxRatePercent	0.219
CY2023Q1	chk	Estimated Effective Income Tax Rate Percent EstimatedEffectiveIncomeTaxRatePercent	0.225
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	77000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.575
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	175000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.29
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2000000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1000000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	21000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000895126-24-000055-index-headers.html	Edgar Link	pending
0000895126-24-000055-index.html	Edgar Link	pending
0000895126-24-000055.txt	Edgar Link	pending
0000895126-24-000055-xbrl.zip	Edgar Link	pending
chk-20240331.htm	Edgar Link	pending
chk-20240331.xsd	Edgar Link	pending
chk-20240331_g1.jpg	Edgar Link	pending
chk-ex_311x20240331x10q.htm	Edgar Link	pending
chk-ex_312x20240331x10q.htm	Edgar Link	pending
chk-ex_321x20240331x10q.htm	Edgar Link	pending
chk-ex_322x20240331x10q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
chk-20240331_def.xml	Edgar Link	unprocessable
chk-20240331_lab.xml	Edgar Link	unprocessable
chk-20240331_htm.xml	Edgar Link	completed
chk-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
chk-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXE
EXPAND ENERGY Corp Stock $exe

2024 Q2 Form 10-Q Financial Statement

#000089512624000055 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXE EXPAND ENERGY Corp Stock $exe

2024 Q2 Form 10-Q Financial Statement

#000089512624000055 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXE
EXPAND ENERGY Corp Stock $exe